Beijing Beilu Pharmaceutical (300016) — Cash Flow Reinvestment Rate
Beijing Beilu Pharmaceutical (300016) has a Cash Flow Reinvestment Rate of 0.78x as of September 2025, reinvesting CN¥57.96 Million (capex CN¥57.96 Million ) from operating cash flow of CN¥74.66 Million. Explore 300016 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Beijing Beilu Pharmaceutical Cash Flow Reinvestment Rate (2006–2024)
Historical reinvestment intensity for Beijing Beilu Pharmaceutical across 18 annual periods. Also explore 300016 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Beijing Beilu Pharmaceutical (2006–2024)
Year-by-year capital reinvestment analysis for Beijing Beilu Pharmaceutical. For live market cap and broader valuation context, see market value of Beijing Beilu Pharmaceutical.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.71x | CN¥115.95 Million | CN¥163.02 Million | CN¥101.39 Million | ▼ -83.9% |
| 2023 | 4.43x | CN¥258.93 Million | CN¥58.46 Million | CN¥144.61 Million | ▲ +182.3% |
| 2022 | 1.57x | CN¥200.55 Million | CN¥127.81 Million | CN¥102.78 Million | ▼ -0.8% |
| 2021 | 1.58x | CN¥171.89 Million | CN¥108.73 Million | CN¥147.76 Million | ▲ +55.9% |
| 2020 | 1.01x | CN¥178.50 Million | CN¥176.00 Million | CN¥172.10 Million | ▲ +92.6% |
| 2019 | 0.53x | CN¥82.57 Million | CN¥156.81 Million | CN¥34.99 Million | ▼ -54.0% |
| 2018 | 1.14x | CN¥201.08 Million | CN¥175.75 Million | CN¥54.06 Million | ▲ +58.8% |
| 2017 | 0.72x | CN¥104.44 Million | CN¥144.92 Million | CN¥55.00 Million | ▼ -77.9% |
| 2016 | 3.25x | CN¥247.91 Million | CN¥76.17 Million | CN¥44.21 Million | ▲ +259.3% |
| 2015 | 0.91x | CN¥73.23 Million | CN¥80.85 Million | CN¥69.23 Million | ▼ -11.3% |
| 2014 | 1.02x | CN¥42.99 Million | CN¥42.11 Million | CN¥42.99 Million | ▲ +19.0% |
| 2013 | 0.86x | CN¥35.48 Million | CN¥41.37 Million | CN¥35.48 Million | ▼ -69.1% |
| 2012 | 2.78x | CN¥63.47 Million | CN¥22.86 Million | CN¥63.47 Million | ▲ +298.4% |
| 2011 | 0.70x | CN¥31.87 Million | CN¥45.73 Million | CN¥31.87 Million | ▼ -49.5% |
| 2010 | 1.38x | CN¥51.77 Million | CN¥37.51 Million | CN¥51.77 Million | ▲ +1403.5% |
| 2009 | 0.09x | CN¥5.32 Million | CN¥57.91 Million | CN¥5.32 Million | ▲ +393.1% |
| 2007 | 0.02x | CN¥228.50K | CN¥12.28 Million | CN¥228.50K | ▼ -75.7% |
| 2006 | 0.08x | CN¥1.51 Million | CN¥19.65 Million | CN¥1.51 Million | — |